LOXL2 and breast carcinoma: Some early preclinical success in this has demonstrated the detection of LOXL2 within both murine and human blood samples of breast cancer patients, where hydrogen peroxide release, a product of LOX family activity, was detected via the use of a gold-based electrochemical biosensor [129].